Tao Wei

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Tingbo Liang · 3 shared papers, 2015–2019 · strength 0.22
   • Paper B7-H5/CD28H is a co-stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma. DOI 10.1111/cas.13914↗
   • Paper Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancre… DOI 10.1016/j.canlet.2019.03.009↗
   • Paper Characteristics of Tumor Infiltrating Lymphocyte and Circulating Lymphocyte Repertoires in Pancreatic Cancer by the Seq… DOI 10.1038/srep13664↗
2. Xueli Bai · 2 shared papers, 2015–2019 · strength 0.14
   • Paper B7-H5/CD28H is a co-stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma. DOI 10.1111/cas.13914↗
   • Paper Characteristics of Tumor Infiltrating Lymphocyte and Circulating Lymphocyte Repertoires in Pancreatic Cancer by the Seq… DOI 10.1038/srep13664↗
3. Jiaqi Yang · 2 shared papers, 2015–2019 · strength 0.12
   • Paper Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancre… DOI 10.1016/j.canlet.2019.03.009↗
   • Paper Characteristics of Tumor Infiltrating Lymphocyte and Circulating Lymphocyte Repertoires in Pancreatic Cancer by the Seq… DOI 10.1038/srep13664↗
4. Jianxin Wang · 1 shared paper, 2019 · strength 0.10
   • Paper B7-H5/CD28H is a co-stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma. DOI 10.1111/cas.13914↗
5. Qi Chen · 1 shared paper, 2019 · strength 0.10
   • Paper B7-H5/CD28H is a co-stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma. DOI 10.1111/cas.13914↗
6. Qi Zhang · 1 shared paper, 2019 · strength 0.10
   • Paper B7-H5/CD28H is a co-stimulatory pathway and correlates with improved prognosis in pancreatic ductal adenocarcinoma. DOI 10.1111/cas.13914↗
7. Qi Chen · 1 shared paper, 2019 · strength 0.08
   • Paper Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancre… DOI 10.1016/j.canlet.2019.03.009↗
8. Xiang Li · 1 shared paper, 2019 · strength 0.08
   • Paper Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancre… DOI 10.1016/j.canlet.2019.03.009↗
9. Tao Ma · 1 shared paper, 2019 · strength 0.08
   • Paper Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancre… DOI 10.1016/j.canlet.2019.03.009↗
10. Jianying Lou · 1 shared paper, 2019 · strength 0.08
    • Paper Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancre… DOI 10.1016/j.canlet.2019.03.009↗
11. Risheng Que · 1 shared paper, 2019 · strength 0.08
    • Paper Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancre… DOI 10.1016/j.canlet.2019.03.009↗
12. Lei Zheng · 1 shared paper, 2019 · strength 0.08
    • Paper Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancre… DOI 10.1016/j.canlet.2019.03.009↗
13. Xueli Bai · 1 shared paper, 2019 · strength 0.08
    • Paper Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancre… DOI 10.1016/j.canlet.2019.03.009↗
14. Qi Zhang · 1 shared paper, 2015 · strength 0.05
    • Paper Characteristics of Tumor Infiltrating Lymphocyte and Circulating Lymphocyte Repertoires in Pancreatic Cancer by the Seq… DOI 10.1038/srep13664↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.